GLP-1 Special Populations

3 articles in this topic.

Complete Guides

GLP-1 Drugs for Teens: The Evidence So Far

Semaglutide and liraglutide are FDA-approved for adolescent obesity. One Phase 3 trial, emerging safety data, and open questions. Evidence from 10 studies.

18 min read|Mar 20, 2026

All Articles

GLP-1 Special Populations

GLP-1 Agonists After Bariatric Surgery

Between 16-37% of bariatric patients regain weight. GLP-1 drugs like semaglutide can recover two-thirds of that regain. Here is what the evidence shows.

13 min read|Mar 22, 2026

GLP-1 Special Populations

GLP-1 Agonists in Older Adults After 65

GLP-1 drugs reduce cardiovascular events in older adults but accelerate muscle and bone loss. Here is what the age-specific evidence shows.

13 min read|Mar 22, 2026